Professor in Pharmaceutical Chemistry, NanoEngineering, and Bioengineering, University of California San Diego.

Professor Almutairi is one of Forbes top ten most influential female engineers in the world, and is a scholar of Science & Engineering, Inventor, and Entrepreneur. 

Member of the Board of Trustees and Directors of several public, private and non-profit Institutes and Corporations, that aim to impact humanity in a positive way, for example the FII Institute, Due Diligence for Venture Capital and Angel Investment. Advisor to Sovereign Wealth Funds, Consultant for several fortune 500 companies.  Inventor on dozens of issued and pending patents. Her patents are licensed to industry and yield lucrative royalties to the University of California. Expert witness on patent litigation.  Founder of eLux Medical, Inc. a lipolysis medical technology company.  

She has a strong relationship with Investcorp, a $50B investment group. She is the U.S. representative director of this Company on the US Stock market which just completed a $250M SPAC. She sits on the board of Lifera. She sits on the board of Sykle which she personally helped achieve the Patents. 

Invited Lectures: Over 200 invited Lectures given nationally and internationally.

Honors & Awards: Kavli Fellow, Kavli Frontiers of Science by US National Academy of Sciences, Kavli Foundation, and Helmholtz Society, New Innovator Award by the US National Institutes of Health, Thieme Chemistry Award by Elsevier publishing group, PhRMA Foundation Award, The Young Investigator Award by the World Biomaterials Congress, Young Investigator Award by the American Chemical Society, and Emerging Investigator Award by the British Royal Chemical Society.

Member: The American Chemical Society (ACS) (2000-present), the Materials Research Society (2000-present); Member, the Society for Biomaterials (by invitation only 2006-present) Member, the Society of Nuclear Medicine (SNM) (2008-present).